pfizer/biontech vaccine phase 3 trial dosed 21k subjects with vaccine another 21k got placebo. higher prevalence covid vs. polio meant smaller trial could demo efficacy. since eua, 210 million doses pfizer have been given us. thatâ€™s ton safety data.